Published in Urology on January 01, 2003
Overactive Bladder Education | NCT02505607
Validation of a Real-Time Urodynamic Measure of Urinary Urgency | NCT00909428
Efficacy of Prompted Voiding Therapy in Elderly Hospitalized. | NCT04117126
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome | NCT05221021
Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med (2010) 7.95
A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med (2012) 4.59
Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms. J Clin Microbiol (2013) 2.79
What predicts and what mediates the response of urge urinary incontinence to biofeedback? Neurourol Urodyn (2012) 2.05
The Trial of Mid-Urethral Slings (TOMUS): Design and Methodology. J Appl Res (2008) 2.05
Evidence of a functional effect of transient transurethral catheterization on micturition in women. Int Urogynecol J (2012) 1.96
Prevalence and Clinical Features of Detrusor Underactivity among Elderly with Lower Urinary Tract Symptoms: A Comparison between Men and Women. Korean J Urol (2012) 1.88
Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a randomized double-blinded trial in a canine translational model. Brain (2012) 1.87
Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract (2009) 1.80
Urodynamics, the supine empty bladder stress test, and incontinence severity. Neurourol Urodyn (2010) 1.66
The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol (2004) 1.57
Enterococcus faecalis subverts and invades the host urothelium in patients with chronic urinary tract infection. PLoS One (2013) 1.56
Urinary incontinence and risk of functional decline in older women: data from the Norwegian HUNT-study. BMC Geriatr (2013) 1.51
Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey. BJU Int (2011) 1.50
Pre-operative urodynamics in women with stress urinary incontinence increases physician confidence, but does not improve outcomes. Neurourol Urodyn (2013) 1.49
Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol (2005) 1.49
A cohort study comparing a single-incision sling with a retropubic midurethral sling. Int Urogynecol J (2013) 1.49
TRP channels in lower urinary tract dysfunction. Br J Pharmacol (2014) 1.48
The role of phosphodiesterases in bladder pathophysiology. Nat Rev Urol (2013) 1.45
Design of the Value of Urodynamic Evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigations. Contemp Clin Trials (2009) 1.44
Muscarinic receptors in the bladder: from basic research to therapeutics. Br J Pharmacol (2006) 1.44
Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women. Int Urogynecol J (2010) 1.43
Self-reported estrogen use and newly incident urinary incontinence among postmenopausal community-dwelling women. Menopause (2012) 1.41
Efficacy of botulinum toxin type A 100 Units versus 200 units for treatment of refractory idiopathic overactive bladder. Int Braz J Urol (2016) 1.40
Physician Use of Sacral Neuromodulation Among Medicare Beneficiaries With Overactive Bladder and Urinary Retention. Urology (2015) 1.40
Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review. Arch Intern Med (2007) 1.38
Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet Gynecol (2011) 1.35
Therapeutic receptor targets for lower urinary tract dysfunction. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.25
Bulking agents: an analysis of 500 cases and review of the literature. Int Urogynecol J (2012) 1.25
Patients' understanding of pelvic floor disorders: what women want to know. Female Pelvic Med Reconstr Surg (2012) 1.11
The impact of overactive bladder on health-related quality of life, sexual life and psychological health in Korea. Int Neurourol J (2011) 1.10
Has the true prevalence of voiding difficulty in urogynecology patients been underestimated? Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.10
Epidemiological study of urge urinary incontinence and risk factors in China. Int Urogynecol J (2010) 1.09
Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey. Urology (2009) 1.09
MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome. Am J Pathol (2009) 1.07
Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life. Res Rep Urol (2013) 1.06
Prediction of successful voiding immediately after outpatient mid-urethral sling. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.06
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels. PLoS One (2013) 1.03
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract (2013) 1.03
Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int J Endocrinol (2014) 1.01
An epidemiological study of urinary incontinence and its impact on quality of life among women aged 35 years and above in a rural area. Indian J Urol (2010) 1.01
Assessment of pelvic floor muscle contraction in stress urinary incontinent women: comparison between transabdominal ultrasound and perineometry. Int Urogynecol J Pelvic Floor Dysfunct (2009) 1.00
Ethnicity and variations of pelvic organ prolapse bother. Int Urogynecol J (2013) 1.00
Male urinary incontinence: prevalence, risk factors, and preventive interventions. Rev Urol (2009) 0.99
Risk factors for urinary, fecal, or dual incontinence in the Nurses' Health Study. Obstet Gynecol (2013) 0.98
A phase II dose-ranging study of mirabegron in patients with overactive bladder. Int Urogynecol J (2013) 0.98
Circadian variation of voided volume in normal school-age children. Eur J Pediatr (2006) 0.98
A nationwide survey to measure practice variation of catheterisation management in patients undergoing vaginal prolapse surgery. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.97
Solifenacin significantly improves all symptoms of overactive bladder syndrome. Int J Clin Pract (2006) 0.96
Association of diuretic use and overactive bladder syndrome in older adults: a propensity score analysis. Arch Gerontol Geriatr (2008) 0.96
Beyond incontinence: the stigma of other urinary symptoms. J Adv Nurs (2010) 0.95
Prevalence of major levator abnormalities in symptomatic patients with an underactive pelvic floor contraction. Int Urogynecol J (2010) 0.95
Quality of life in women with multiple sclerosis and overactive bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.94
Dual simulated childbirth injury delays anatomic recovery. Am J Physiol Renal Physiol (2008) 0.94
Various surgical approaches to treat voiding dysfunction following anti-incontinence surgery. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.93
Bladder dysfunction in mice with experimental autoimmune encephalomyelitis. J Neuroimmunol (2008) 0.93
Urinary incontinence in women: prevalence rates, risk factors and impact on quality of life. Pak J Med Sci (2013) 0.93
Pelvic floor muscle training for urgency urinary incontinence in women: a systematic review. Int Urogynecol J (2012) 0.93
Analysis of risk factors associated with surgical failure of inside-out transobturator vaginal tape for treating urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.92
Effect of Urinary Incontinence on Quality of Life among Iranian Women. J Family Reprod Health (2014) 0.92
Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome. J Urol (2010) 0.92
Postpartum stress urinary incontinence: lessons from animal models. Expert Rev Obstet Gynecol (2010) 0.91
Botulinum toxin in neurogenic detrusor overactivity. Int Neurourol J (2012) 0.91
Impact of tension-free vaginal tape on sexual function: results of a prospective study. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.91
Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence. BMC Urol (2009) 0.91
The relationship between irritable bowel syndrome, functional dyspepsia, chronic fatigue and overactive bladder syndrome: a controlled study 6 years after acute gastrointestinal infection. BMC Gastroenterol (2015) 0.90
Retracted Observational study: daily treatment with a new compound "Tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms. BMC Surg (2012) 0.90
Neurotrophins as regulators of urinary bladder function. Nat Rev Urol (2012) 0.90
Diabetes related risk factors did not explain the increased risk for urinary incontinence among women with diabetes. The Norwegian HUNT/EPINCONT study. BMC Urol (2009) 0.90
Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol (2006) 0.90
Circadian rhythms in urinary functions: possible roles of circadian clocks? Int Neurourol J (2011) 0.89
Interstitial cystitis/bladder pain syndrome: diagnosis and management. Int Urogynecol J (2013) 0.89
Urethral erosion after suburethral synthetic slings: risk factors, diagnosis, and functional outcome after surgical management. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.89
The effect of oral solifenacin succinate treatment on intraocular pressure: glaucoma paradox during overactive bladder treatment. Int Urogynecol J (2014) 0.89
Validation of a global pelvic floor symptom bother questionnaire. Int Urogynecol J (2010) 0.88
Clinical and pathophysiological correlates of the symptom severity of stress urinary incontinence. Int Urogynecol J (2010) 0.88
Overactive bladder syndrome and the potential role of prostaglandins and phosphodiesterases: an introduction. Nephrourol Mon (2013) 0.88
Overactive bladder in males. Ther Adv Urol (2009) 0.88
Symptoms, quality of life, and factors affecting women's treatment decisions regarding pelvic organ prolapse. Int Urogynecol J (2012) 0.88
There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.88
Alteration of autonomic function in female urinary incontinence. Int Neurourol J (2010) 0.88
The puzzle of overactive bladder: controversies, inconsistencies, and insights. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.87
Tension-free vaginal tape for the treatment of urodynamic stress incontinence with intrinsic sphincteric deficiency. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.87
Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durability. Adv Urol (2011) 0.87
Effect of caffeine on bladder function in patients with overactive bladder symptoms. Urol Ann (2011) 0.87
Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction. Br J Clin Pharmacol (2011) 0.87
In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder. Br J Pharmacol (2009) 0.87
A systematic review of the treatment for female stress urinary incontinence by ACT® balloon placement (Uromedica, Irvine, CA, USA). World J Urol (2013) 0.87
Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.86
Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women. Am J Epidemiol (2013) 0.86
Randomized Comparative Study of the U- and H-Type Approaches of the TVT-Secur Procedure for the Treatment of Female Stress Urinary Incontinence: One-Year Follow-Up. Korean J Urol (2010) 0.86
Stem cells for urinary tract regeneration. Cent European J Urol (2012) 0.86
Prevalence and risk factors for urinary incontinence in healthy pregnant Brazilian women. Int Urogynecol J (2010) 0.86
Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.it. Ther Adv Urol (2012) 0.86
Dietary macronutrient and energy intake and urinary incontinence in women. Am J Epidemiol (2010) 0.86
Development of a device to standardize leak point pressure experiments in rats. Neurourol Urodyn (2008) 0.85
Role of µ, κ, and δ Opioid Receptors in Tibial Inhibition of Bladder Overactivity in Cats. J Pharmacol Exp Ther (2015) 0.85
Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo. Health Qual Life Outcomes (2009) 0.85
Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.85
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn (2002) 22.80
Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol (2007) 4.41
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol (2002) 4.31
The neural control of micturition. Nat Rev Neurosci (2008) 4.19
Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol (2007) 3.61
A new classification is needed for pelvic pain syndromes--are existing terminologies of spurious diagnostic authority bad for patients? J Urol (2006) 2.13
Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity? Eur Urol (2008) 2.12
Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy. Eur Urol (2007) 2.11
Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn (2003) 2.07
What predicts and what mediates the response of urge urinary incontinence to biofeedback? Neurourol Urodyn (2012) 2.05
Standardization of terminology of pelvic floor muscle function and dysfunction: report from the pelvic floor clinical assessment group of the International Continence Society. Neurourol Urodyn (2005) 2.04
FOR: women should be free to opt for cosmetic genital surgery. BJOG (2014) 1.94
A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol (2009) 1.86
Can ultrasound replace ambulatory urodynamics when investigating women with irritative urinary symptoms? BJOG (2002) 1.74
P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2004) 1.61
Pregnancy and delivery following tension-free vaginal tape. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.60
Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. Int Urogynecol J (2009) 1.60
Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Neurourol Urodyn (2010) 1.55
Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis. Int J Urol (2014) 1.52
Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level. Eur Urol (2007) 1.52
Standardisation of urethral pressure measurement: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn (2002) 1.51
Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J Urol (2004) 1.51
Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int (2006) 1.50
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Int J Urol (2006) 1.50
Brain activity underlying impaired continence control in older women with overactive bladder. Neurourol Urodyn (2012) 1.50
Urethral diverticula: a diagnostic dilemma. BJU Int (2004) 1.49
The effect of mode of delivery on pelvic floor functional anatomy. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.48
Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder. BJU Int (2013) 1.47
Antimuscarinic drugs to treat overactive bladder. BMJ (2012) 1.44
Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ). Eur Urol (2006) 1.43
Constructing trials to show whether urodynamic studies are necessary in lower urinary tract dysfunction. Neurourol Urodyn (2011) 1.43
Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder? BJU Int (2013) 1.41
Quality control in urodynamics: Analysis of an international multi-center study. Neurourol Urodyn (2009) 1.40
Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder. Eur Urol (2007) 1.40
Role of urodynamics before prolapse surgery. Int Urogynecol J (2014) 1.39
Transdermal oxybutynin: sticking to the facts. Eur Urol (2006) 1.39
The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study. Eur J Obstet Gynecol Reprod Biol (2011) 1.39
Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn (2009) 1.37
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev (2005) 1.37
Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm (2014) 1.36
Overactive bladder and painful bladder syndrome: there need not be confusion. Neurourol Urodyn (2005) 1.23
Abnormal connections in the supraspinal bladder control network in women with urge urinary incontinence. Neuroimage (2007) 1.21
Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol (2009) 1.19
Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn (2013) 1.17
A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct (2003) 1.16
Publish or be damned? The fate of abstracts presented at the International Continence Society Meeting 2003. Neurourol Urodyn (2007) 1.11
Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol (2002) 1.09
Interstitial cystitis: diagnosis and management. Eur J Obstet Gynecol Reprod Biol (2012) 1.08
A review of adherence to drug therapy in patients with overactive bladder. BJU Int (2008) 1.06
Stop test or pressure-flow study? Measuring detrusor contractility in older females. Neurourol Urodyn (2004) 1.06
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand (2002) 1.06
The effect of hormones on the lower urinary tract. Menopause Int (2013) 1.06
Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int (2005) 1.06
A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome. BJU Int (2007) 1.03
Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J (2012) 1.03
Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder. BJU Int (2010) 1.02
Surgical treatment for female stress urinary incontinence: what is the gold-standard procedure? Int Urogynecol J Pelvic Floor Dysfunct (2009) 1.02
Brain activity during bladder filling is related to white matter structural changes in older women with urinary incontinence. Neuroimage (2010) 1.01
Technique of urethral retro-resistance pressure measurement. Neurourol Urodyn (2004) 1.00
Overactive bladder syndrome in older people. BJU Int (2007) 0.99
Bladder pain syndrome. Med Clin North Am (2011) 0.99
A phase II dose-ranging study of mirabegron in patients with overactive bladder. Int Urogynecol J (2013) 0.98
Overactive bladder: Is there a link to the metabolic syndrome in men? Neurourol Urodyn (2010) 0.98
New insights into perinatal testicular torsion. Eur J Pediatr (2009) 0.97
Is there a discrepancy between patient and physician quality of life assessment? Neurourol Urodyn (2009) 0.96
Normative bladder diary measurements: night versus day. Neurourol Urodyn (2007) 0.96
Which stop test is best? Measuring detrusor contractility in older females. J Urol (2003) 0.95
Role of urothelial nerve growth factor in human bladder function. Neurourol Urodyn (2007) 0.95
What are the causes and consequences of bladder overdistension? ICI-RS 2011. Neurourol Urodyn (2012) 0.95
Oestrogens and overactive bladder. Neurourol Urodyn (2013) 0.94
Bladder diary volume per void measurements in detrusor overactivity. J Urol (2006) 0.94
Brain activity measured by functional magnetic resonance imaging is related to patient reported urgency urinary incontinence severity. J Urol (2010) 0.94
Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome. Scand J Urol Nephrol (2005) 0.93
Psychological morbidity and female urinary incontinence. Best Pract Res Clin Obstet Gynaecol (2007) 0.92
Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology (2007) 0.92
Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol (2003) 0.92
Out-of-pocket expenses and treatment choice for men with prostate cancer. Urology (2012) 0.92
Induction of apoptosis and G2/M arrest by 2-methoxyestradiol in human cervical cancer HeLaS3 cells. Anticancer Res (2004) 0.92
Urovaginal fistula formation after gynaecological and obstetric surgical procedures: clinical experiences in a Scandinavian series. Scand J Urol (2012) 0.91
Alteration of contractile and regulatory proteins following partial bladder outlet obstruction. Scand J Urol Nephrol Suppl (2004) 0.91
Can we prevent incontinence? ICI-RS 2011. Neurourol Urodyn (2012) 0.91
A prospective observational trial of pelvic floor muscle training for female stress urinary incontinence. BJU Int (2006) 0.90